 |
FDA Approval Activities for this Drug
Mandol (cefamandole nafate) Injection, Eli Lilly and Company NDA 50-504/S-062 3/4/03 3/10/03
Mandol (cefamandole nafate) Vials, Eli Lilly and Company NDA 50-504/S-059
For the most up-to-date approval information, please locate this API using the drug index.
|